Persistent cyclooxygenase-2 inhibition downregulates NF-{kappa}B, resulting in chronic intestinal inflammation in the min/+ mouse model of colon tumorigenesis.
about
The wound healing, chronic fibrosis, and cancer progression triadInhibition of intestinal adenoma formation in APC(Min/+) mice by Riccardin D, a natural product derived from liverwort plant Dumortiera hirsutaThe tumor microenvironment of colorectal cancer: stromal TLR-4 expression as a potential prognostic markerExpression and significance of HMGB1, TLR4 and NF-κB p65 in human epidermal tumors.Sulindac reversal of 15-PGDH-mediated resistance to colon tumor chemoprevention with NSAIDs.Prebiotic treatment reduced preneoplastic lesions through the downregulation of toll like receptor 4 in a chemo-induced carcinogenic model.A critical role for macrophages in promotion of urethane-induced lung carcinogenesisA Novel Peroxisome Proliferator-activated Receptor (PPAR)γ Agonist 2-Hydroxyethyl 5-chloro-4,5-didehydrojasmonate Exerts Anti-Inflammatory Effects in ColitisAssociation of stem-like cells in gender-specific chemoprevention against intestinal neoplasia in MIN mouse.Biologic determinants of tumor recurrence in stage II colon cancer: validation study of the 12-gene recurrence score in cancer and leukemia group B (CALGB) 9581.Low doses of celecoxib attenuate gut barrier failure during experimental peritonitis.Exogenous or endogenous Toll-like receptor ligands: which is the MVP in tumorigenesis?Celecoxib increases EGF signaling in colon tumor associated fibroblasts, modulating EGFR expression and degradation.Obesity-associated cancer risk: the role of intestinal microbiota in the etiology of the host proinflammatory state.Inhibition of nuclear factor-κB signaling suppresses Spint1-deletion-induced tumor susceptibility in the ApcMin/+ model.Celecoxib inactivates epithelial-mesenchymal transition stimulated by hypoxia and/or epidermal growth factor in colon cancer cells.Colonic delivery of celecoxib is a potential pharmaceutical strategy for repositioning the selective COX-2 inhibitor as an anti-colitic agent.Suppression of the NF‑κB signaling pathway in colon cancer cells by the natural compound Riccardin D from Dumortierahirsute.
P2860
Q27014616-59AB2340-E0F3-4F16-8180-708F9CD49011Q28481494-620837B6-A756-4E56-B738-075D462676B2Q34380094-3BC35D95-CBBB-4E53-AF09-A67119F07462Q34784913-88D8730F-B098-4988-8B96-2951D1A122BDQ35065261-661CEAD6-3EA8-4EA4-AA71-E43380F999FEQ35082860-01D04A73-2C3F-4FA2-9681-47978FC40711Q35566757-D2F1AA1F-D19C-4324-BA02-A03CC316327CQ36283368-B40F2DED-86DB-4645-9CDF-E2D5BB08E99AQ36570730-E31846A3-20DD-4014-B3BD-0C2B0CB76D87Q36810728-9AE1F65C-2BD0-4AC2-9A63-BF0CE37844F0Q37665071-472FDE7C-1A3F-4983-BC39-990C9B2BBC16Q37952071-5943C45E-E026-4E35-A57A-A624B65E648FQ38873392-7562CD29-982E-4EA7-9B8D-9FFB3772D2B4Q38927355-F3815CEB-86A7-42B3-8CE0-0F0B92FF00F3Q42254033-E28C3B69-A78D-42DC-BE43-B080B19E38D9Q42493683-BBE6FEDC-65DA-4E3D-9369-C6C1F13EE54AQ50990866-66D60D8F-17D1-43DE-A27E-8F14D0A944FDQ52684026-6C423A3B-DBC5-4500-A8C2-7FBB50A50802
P2860
Persistent cyclooxygenase-2 inhibition downregulates NF-{kappa}B, resulting in chronic intestinal inflammation in the min/+ mouse model of colon tumorigenesis.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Persistent cyclooxygenase-2 in ...... model of colon tumorigenesis.
@en
Persistent cyclooxygenase-2 in ...... model of colon tumorigenesis.
@nl
type
label
Persistent cyclooxygenase-2 in ...... model of colon tumorigenesis.
@en
Persistent cyclooxygenase-2 in ...... model of colon tumorigenesis.
@nl
prefLabel
Persistent cyclooxygenase-2 in ...... model of colon tumorigenesis.
@en
Persistent cyclooxygenase-2 in ...... model of colon tumorigenesis.
@nl
P2093
P2860
P1433
P1476
Persistent cyclooxygenase-2 in ...... model of colon tumorigenesis.
@en
P2093
Adelaide M Carothers
Beatrice C Damas
Jennifer S Davids
Monica M Bertagnolli
P2860
P304
P356
10.1158/0008-5472.CAN-09-4289
P407
P577
2010-05-18T00:00:00Z